PERCEPTIVE ADVISORS LLC Q2 2017 Filing

Filed August 14, 2017

Portfolio Value

$2.0T

Holdings

124

Report Date

Q2 2017

Filing Type

13F-HR

All Holdings (124 positions)

#StockSharesValue% PortfolioType
101
INCYINCYTE CORP
5,619$707.0M0.04%
102
ZOSANO PHARMA CORP
500,000$705.0M0.04%
103
STLAFIAT CHRYSLER AUTOMOBILES N
62,000$659.0M0.03%
104
HRCHILL ROM HLDGS INC
7,930$631.0M0.03%
105
ACORDA THERAPEUTICS INC
31,786$626.0M0.03%
106
CNCCENTENE CORP DEL
7,726$617.0M0.03%
107
ACHAOGEN INC
27,551$599.0M0.03%
108
VNDAVANDA PHARMACEUTICALS INC
36,232$591.0M0.03%
109
MOHMOLINA HEALTHCARE INC
8,140$563.0M0.03%
110
RACEFERRARI N V
6,200$533.0M0.03%
111
PROTEON THERAPEUTICS INC
334,116$518.0M0.03%
112
ICLRICON PLC
5,187$507.0M0.03%
113
INC RESH HLDGS INC
8,532$499.0M0.03%
114
CIDARA THERAPEUTICS INC
62,110$465.0M0.02%
115
DIPLOMAT PHARMACY INC
30,658$454.0M0.02%
116
PORTOLA PHARMACEUTICALS INC
7,870$442.0M0.02%
117
CUTREURCUTERA INC
11,981$310.0M0.02%
118
VYGRVOYAGER THERAPEUTICS INC
34,604$310.0M0.02%
119
PERNIX THERAPEUTICS HLDGS IN
1,000,000$282.0M0.01%
120
ACASTI PHARMA INC
186,559$247.0M0.01%
121
ARNO THERAPEUTICS INC
4,177,577$208.0M0.01%
122
ONCOBIOLOGICS INC
462,500$80.0M0.00%
123
ONCOBIOLOGICS INC
462,500$42.0M0.00%
124
PEREGRINE PHARMACEUTICALS IN
24,332$15.0M0.00%
PreviousPage 2 of 2